BOCA RATON, Fla., July 11, 2011 /PRNewswire/ — Vycor Medical,
Inc. announces that Alvaro Pascual-Leone, MD, PhD has
agreed to be the Head of the Strategic Advisory Board of its
NovaVision, Inc. subsidiary.
Alvaro Pascual-Leone, MD, PhD, is Professor of Neurology at
Harvard Medical School; Director of the Berenson-Allen Center for
Noninvasive Brain Stimulation; Program Director of the
Harvard-Thorndike Clinical Research Unit; and an Attending
Neurologist at Beth Israel Deaconess Medical Center — all in
Boston. He is a practicing behavioral neurologist and movement
disorders specialist.
A native of Spain, Dr. Pascual-Leone received his M.D. in 1984
and his Ph.D. in Neurophysiology in 1985, both from Albert-Ludwigs
University in Freiburg, Germany. Following an internship in
Medicine at Staedtisches Klinikum Karlsruhe in Germany and
residency in Internal Medicine at Hospital Universitario de
Valencia in Spain, Dr. Pascual-Leone completed a Neurology
residency at the University of Minnesota, and then trained in
Clinical Neurophysiology and Human Motor Control at the University
of Minnesota and the National Institutes of Health (NIH). He joined
Harvard Medical School and Beth Israel Deaconess Medical Center in
1997, after several years at the Cajal Institute of the Spanish
Research Council.
Dr. Pascual-Leone is a world leader in research and development,
clinical application and teaching of noninvasive brain stimulation.
Dr. Pascual-Leone’s research aims at understanding the mechanisms
that control brain plasticity across the life span to be able to
modify them for the patient’s optimal behavioral outcome. Dr.
Pascual-Leone has authored more than 450 scientific papers as well
as several books, and holds various patents.
Dr. Pascual-Leone is also the recipient of several international
honors and awards, including the Ramón y Cajal Award in
Neuroscience (Spain), the Norman Geschwind Prize in Behavioral
Neurology from t
‘/>”/>
